BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31037729)

  • 1. In-vitro and in situ assessment of the efflux of five antidepressants by breast cancer resistance protein.
    Feng S; Zheng L; Tang S; Gu J; Jiang X; Wang L
    J Pharm Pharmacol; 2019 Jul; 71(7):1133-1141. PubMed ID: 31037729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilizing a Dual Human Transporter MDCKII-MDR1-BCRP Cell Line to Assess Efflux at the Blood Brain Barrier.
    Colclough N; Alluri RV; Tucker JW; Gozalpour E; Li D; Du H; Li W; Harlfinger S; O'Neill DJ; Sproat GG; Chen K; Yan Y; McGinnity DF
    Drug Metab Dispos; 2024 Jan; 52(2):95-105. PubMed ID: 38071533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier.
    Li Y; Wu Q; Li C; Liu L; Du K; Shen J; Wu Y; Zhao X; Zhao M; Bao L; Gao J; Keep RF; Xiang J
    PLoS One; 2016; 11(6):e0157576. PubMed ID: 27300692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer resistance protein interacts with various compounds in vitro, but plays a minor role in substrate efflux at the blood-brain barrier.
    Zhao R; Raub TJ; Sawada GA; Kasper SC; Bacon JA; Bridges AS; Pollack GM
    Drug Metab Dispos; 2009 Jun; 37(6):1251-8. PubMed ID: 19273529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation into the impact of proton pump inhibitors on sertraline transport across the blood-brain barrier.
    Xiao Y; Xu W; Niu D; Quan Z; Wang L
    Eur J Pharm Sci; 2024 Mar; 194():106653. PubMed ID: 38006986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combo-strategy to improve brain delivery of antiepileptic drugs: Focus on BCRP and intranasal administration.
    Gonçalves J; Silva S; Gouveia F; Bicker J; Falcão A; Alves G; Fortuna A
    Int J Pharm; 2021 Jan; 593():120161. PubMed ID: 33307160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic Cation Transporters are Involved in Fluoxetine Transport Across the Blood-Brain Barrier
    Wang M; Sun Y; Hu B; He Z; Chen S; Qi D; An H; Wei Y
    Curr Drug Deliv; 2022; 19(4):508-517. PubMed ID: 34238184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human P-glycoprotein differentially affects antidepressant drug transport: relevance to blood-brain barrier permeability.
    O'Brien FE; Clarke G; Dinan TG; Cryan JF; Griffin BT
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2259-72. PubMed ID: 23931269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Endogenous Breast Cancer Resistance Protein on Human P-Glycoprotein-Mediated Transport Assays Using LLC-PK1 Cells Transfected With Human P-Glycoprotein.
    Miyamoto R; Nozawa T; Shiozuka K; Tabata K
    J Pharm Sci; 2019 Mar; 108(3):1085-1089. PubMed ID: 30339864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of LW6 as a new potent inhibitor of breast cancer resistance protein.
    Song JG; Lee YS; Park JA; Lee EH; Lim SJ; Yang SJ; Zhao M; Lee K; Han HK
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):735-44. PubMed ID: 27520631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Drug Transport in MDCKII-Wild Type, MDCKII-MDR1, MDCKII-BCRP and Caco-2 Cell Lines.
    Mukkavilli R; Jadhav G; Vangala S
    Curr Pharm Biotechnol; 2017; 18(14):1151-1158. PubMed ID: 29521222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein.
    Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
    Eur J Pharm Sci; 2018 May; 117():35-40. PubMed ID: 29428540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
    Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated system exposures of baicalin after combinatory oral administration of rhein and baicalin: Mainly related to breast cancer resistance protein (ABCG2), not UDP-glucuronosyltransferases.
    Zhang Y; Zhang M; Hu G; Zhang Z; Song R
    J Ethnopharmacol; 2020 Mar; 250():112528. PubMed ID: 31884038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (67/68)Galmydar: A metalloprobe for monitoring breast cancer resistance protein (BCRP)-mediated functional transport activity.
    Sivapackiam J; Harpstrite SE; Prior JL; Mattingly S; Sharma V
    Nucl Med Biol; 2016 Mar; 43(3):191-7. PubMed ID: 26924499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.
    Cerveny L; Pavek P; Malakova J; Staud F; Fendrich Z
    Epilepsia; 2006 Mar; 47(3):461-8. PubMed ID: 16529607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells.
    Ye L; Yang X; Yang Z; Gao S; Yin T; Liu W; Wang F; Hu M; Liu Z
    Toxicol Lett; 2013 Feb; 216(2-3):86-99. PubMed ID: 23200901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Human Brain Penetration of P-glycoprotein and Breast Cancer Resistance Protein Substrates Using In Vitro Transporter Studies and Animal Models.
    Feng B; Doran AC; Di L; West MA; Osgood SM; Mancuso JY; Shaffer CL; Tremaine L; Liras J
    J Pharm Sci; 2018 Aug; 107(8):2225-2235. PubMed ID: 29608887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of ATP-binding cassette transporters in the intestinal transport of rhein.
    Ye L; Lu L; Li Y; Zeng S; Yang X; Chen W; Feng Q; Liu W; Tang L; Liu Z
    Food Chem Toxicol; 2013 Aug; 58():301-5. PubMed ID: 23665409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein.
    Lee YJ; Kusuhara H; Jonker JW; Schinkel AH; Sugiyama Y
    J Pharmacol Exp Ther; 2005 Jan; 312(1):44-52. PubMed ID: 15448171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.